Avior Wealth Management’s CureVac CVAC Stock Holding History

Avior Wealth Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10	Closed	-$104	–	1608
2023 Q2	$104	Buy	+10	New	+$89	﹤0.01%	1523

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Avior Wealth Management's CVAC Position: Q3 2023 in Review

Avior Wealth Management sold out of CureVac (CVAC) in Q3 2023, closing a stake of 10 shares — an estimated $104 sold.

Avior Wealth Management first reported a position in CVAC in Q2 2023 and held it in 1 quarter. The position peaked at $104 in Q2 2023. 84 funds tracked by Wall St. Rank hold CVAC as of Q3 2023.

Avior Wealth Management reported no remaining CureVac position as of Q3 2023 after selling out during the quarter.
Avior Wealth Management sold 10 CureVac shares in Q3 2023, an estimated $104.
Avior Wealth Management first reported a position in CureVac in Q2 2023 and held it in 1 quarter.
Avior Wealth Management's CureVac position peaked at $104 in Q2 2023.
84 funds tracked by Wall St. Rank held CureVac as of Q3 2023.

Based on Avior Wealth Management's 13F filing for Q3 2023, filed 17 Oct 2023.